Northwestern’s Center for Heart Valve Disease at the Bluhm Cardiovascular Institute is led by Patrick M. McCarthy, MD and Robert O. Bonow, MD. Dr. McCarthy is an internationally known cardiac surgeon who specializes in valve repairs and is an innovator of valve repair techniques. Dr. Bonow is a cardiologist who specializes in medical treatment for valve disease and a past chair of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines of Patients With Valvular Heart Disease.
Patients that come to the Center for Heart Valve Disease benefit from highly skilled physicians and sophisticated clinical programs that are designed to address specific valvular diagnoses and associated atrial fibrillation, including:
- Transcatheter aortic valve replacement
- Bicuspid aortic valve
- Marfan syndrome and related disorders
- Mitral valve disease
- Aortic valve disease
- Tricuspid valve disease
- Atrial fibrillation
In 2013-14, U.S. News & World Report ranked Northwestern's Cardiology and Heart Surgery program
- #1 in the Chicago metro region
- #1 in Illinois for the sixth straight year
- #12 in the nation out of 720 cardiac programs
- Highest ranked cardiac program in the region: Indiana, Michigan, Wisconsin, Missouri and Iowa
Northwestern Memorial Hospital ranks #6 in the nation in the U.S. News & World Report 2013-14 Honor Roll of America’s Best Hospitals. The hospital is recognized in 14 of 16 clinical specialties and is #1 in Illinois and Chicago in the state and metro rankings, respectively.
At Northwestern's Bluhm Cardiovascular Institute, we evaluate our clinical outcomes so that we can fully understand how our treatments and procedures benefit our patients. We offer the latest advances in cardiovascular care, including innovative treatment, promising research and multidisciplinary support.
It is a priority among the cardiologists and cardiac surgeons at the Center for Heart Valve Disease to repair rather than replace heart valves whenever possible to preserve a patient’s own heart valve so that blood thinning (anticoagulation) medications are not required.
When repair is not possible, we typically replace diseased heart valves with bioprosthetic (tissue) valves – 96.8% of our isolated aortic valve replacements receive tissue valves and 92.5% of isolated aortic valve replacements receive tissue valves. Patients that receive bioprosthetic valves do not require anticoagulants.
Specific to aortic valve procedures, Northwestern’s operative mortality for both isolated replacement and replacement + bypass surgery is again, well under the national averages for these procedures.
To learn more about the clinical outcomes at the Northwestern's Center for Heart Valve Disease, please visit our Clinical Activities and Outcomes microsite.
To contact our heart valve clinic, please contact:
Eileen McDonald, RN, BSN
Our clinic accepts most major insurance carriers.
Our clinic is located at:
Northwestern Memorial Hospital
675 North St. Clair St.
Chicago, Illinois 60611
A map of our clinic is provided below.